Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Channelview, TX
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Channelview, TX
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Forth Worth, TX
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Forth Worth, TX
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Groesbeck, TX
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Groesbeck, TX
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Houston, TX
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Plano, TX
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Plano, TX
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
San Antonio, TX
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Chesapeake, VA
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Chester, VA
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Chester, VA
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Tacoma, WA
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Clarksburg, WV
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Clarksburg, WV
Click here to add this to my saved trials
Lubiprostone Effect on Gastrointestinal (GI) Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation
The Effect of Lubiprostone on Transit Times Within the Alimentary Tract, Measured by Novel Smartpill Methodology in Patients With Chronic Constipation
Status: Enrolling
Updated:  11/20/2015
Texas Tech University Health Sciences Center
mi
from
El Paso, TX
Lubiprostone Effect on Gastrointestinal (GI) Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation
The Effect of Lubiprostone on Transit Times Within the Alimentary Tract, Measured by Novel Smartpill Methodology in Patients With Chronic Constipation
Status: Enrolling
Updated: 11/20/2015
Texas Tech University Health Sciences Center
mi
from
El Paso, TX
Click here to add this to my saved trials
Effect of Octreotide on the Colonic Motility in Pediatric Patients
Effect of Octreotide on the Colonic Motility in Pediatric Patients
Status: Enrolling
Updated:  12/17/2015
Motility Laboratory, Division of Pediatric Gastroenterology, Hepatology and Nutrition at the James Whitcomb Riley Hospital for Children,
mi
from
Indianapolis, IN
Effect of Octreotide on the Colonic Motility in Pediatric Patients
Effect of Octreotide on the Colonic Motility in Pediatric Patients
Status: Enrolling
Updated: 12/17/2015
Motility Laboratory, Division of Pediatric Gastroenterology, Hepatology and Nutrition at the James Whitcomb Riley Hospital for Children,
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
Phase II Trial of Subcutaneous Methylnaltrexone in the Treatment of Severe Opioid-induced Constipation in Cancer Patients
Status: Enrolling
Updated:  12/29/2015
Fletcher Allen Health Care
mi
from
Burlington, VT
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
Phase II Trial of Subcutaneous Methylnaltrexone in the Treatment of Severe Opioid-induced Constipation in Cancer Patients
Status: Enrolling
Updated: 12/29/2015
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Southern California
mi
from
Los Angeles, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Colorado Neurological Institute
mi
from
Englewood, CO
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Colorado Neurological Institute
mi
from
Englewood, CO
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Florida Center for Movement Disorders and Neurorestoration
mi
from
Gainesville, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Florida Center for Movement Disorders and Neurorestoration
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Emory University/ Wesley Woods Health Center
mi
from
Atlanta, GA
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Emory University/ Wesley Woods Health Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Augusta University
mi
from
Augusta, GA
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Iowa Hospitals, Movement Disorders Div, Dept of Neurology
mi
from
Iowa City, IA
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Iowa Hospitals, Movement Disorders Div, Dept of Neurology
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Michigan State University
mi
from
East Lansing, MI
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Henry Ford West Bloomfield Hospital
mi
from
West Bloomfield, MI
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Henry Ford West Bloomfield Hospital
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Atlantic Neuroscience
mi
from
Summit, NJ
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Atlantic Neuroscience
mi
from
Summit, NJ
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Rochester
mi
from
Rochester, NY
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Toledo Medical Center
mi
from
Toledo, OH
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Toledo Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Movement Disorders Program & The Parkinson's Center of Oregon
mi
from
Portland, OR
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Movement Disorders Program & The Parkinson's Center of Oregon
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Pennsylvania, Penn Neurological Institute
mi
from
Philadelphia, PA
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Pennsylvania, Penn Neurological Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
Status: Enrolling
Updated:  1/5/2016
Compass Research LLC
mi
from
Orlando, FL
Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
Status: Enrolling
Updated: 1/5/2016
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
Status: Enrolling
Updated:  1/5/2016
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
Status: Enrolling
Updated: 1/5/2016
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Birmingham, AL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Foley, AL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Foley, AL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Gulf Shores, AL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Gulf Shores, AL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Huntsville, AL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
North Mobile, AL
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
North Mobile, AL
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Mesa, AZ
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Peoria, AZ
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Tucson, AZ
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Hot Springs, AR
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Little Rock, AR
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
North Little Rock, AR
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Artesia, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Artesia, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Carlsbad, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Cerritos, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Cerritos, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Chula Vista, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Escondido, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Escondido, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Fairfield, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Fairfield, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Foothill Ranch, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Foothill Ranch, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Fresno, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Garden Grove, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated:  1/5/2016
Clinical Research Facility
mi
from
Huntington Park, CA
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3 Study to Evaluate the Long-Term Safety and Tolerability of CB-5945 for the Treatment of Opioid-Induced Constipation in Adults Taking Opioid Therapy for Chronic Non-Cancer Pain
Status: Enrolling
Updated: 1/5/2016
Clinical Research Facility
mi
from
Huntington Park, CA
Click here to add this to my saved trials